Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1989 Jun;44(6):449–454. doi: 10.1136/thx.44.6.449

Treatment of pulmonary disease caused by opportunist mycobacteria.

J Banks 1
PMCID: PMC1020802  PMID: 2669223

Abstract

Opportunist mycobacterial infections localised to the chest may be treated with combinations of standard antimycobacterial drugs. The combination of rifampicin and ethambutol seems to be particularly effective, both in vivo and in vitro. In vitro sensitivity testing with single drugs may have a role in the future when the levels of in vitro resistance compatible with the clinical response to treatment are eventually established. Sensitivity testing against drugs in combination may prove useful for modifying treatment regimens in those patients who either fail to respond to initial chemotherapy or relapse. Further evidence on this will, it is hoped, emerge from the prospective studies currently in progress.

Full text

PDF
449

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahn C. H., Lowell J. R., Ahn S. S., Ahn S. I., Hurst G. A. Short-course chemotherapy for pulmonary disease caused by Mycobacterium kansasii. Am Rev Respir Dis. 1983 Dec;128(6):1048–1050. doi: 10.1164/arrd.1983.128.6.1048. [DOI] [PubMed] [Google Scholar]
  2. Bailey W. C. Treatment of atypical mycobacterial disease. Chest. 1983 Nov;84(5):625–628. doi: 10.1378/chest.84.5.625. [DOI] [PubMed] [Google Scholar]
  3. Banks J., Hunter A. M., Campbell I. A., Jenkins P. A., Smith A. P. Pulmonary infection with Mycobacterium kansasii in Wales, 1970-9: review of treatment and response. Thorax. 1983 Apr;38(4):271–274. doi: 10.1136/thx.38.4.271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Banks J., Hunter A. M., Campbell I. A., Jenkins P. A., Smith A. P. Pulmonary infection with mycobacterium xenopi: review of treatment and response. Thorax. 1984 May;39(5):376–382. doi: 10.1136/thx.39.5.376. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Banks J., Jenkins P. A. Combined versus single antituberculosis drugs on the in vitro sensitivity patterns of non-tuberculous mycobacteria. Thorax. 1987 Nov;42(11):838–842. doi: 10.1136/thx.42.11.838. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Banks J., Jenkins P. A., Smith A. P. Pulmonary infection with Mycobacterium malmoense--a review of treatment and response. Tubercle. 1985 Sep;66(3):197–203. doi: 10.1016/0041-3879(85)90037-6. [DOI] [PubMed] [Google Scholar]
  7. Bates J. H. A study of pulmonary disease associated with mycobacteria other than Mycobacterium tuberculosis: clinical characteristics. XX. A report of the Veterans Administration-armed forces cooperative study on the chemotherapy of tuberculosis. Am Rev Respir Dis. 1967 Dec;96(6):1151–1157. doi: 10.1164/arrd.1967.96.6.1151. [DOI] [PubMed] [Google Scholar]
  8. Bogaerts Y., Elinck W., van Renterghem D., Pauwels R., van der Straeten M. Pulmonary disease due to Mycobacterium xenopi. Report of two cases. Eur J Respir Dis. 1982 Jul;63(4):298–304. [PubMed] [Google Scholar]
  9. CARRUTHERS K. J., EDWARDS F. G. ATYPICAL MYCOBACTERIA IN WESTERN AUSTRALIA. Am Rev Respir Dis. 1965 Jun;91:887–895. doi: 10.1164/arrd.1965.91.6.887. [DOI] [PubMed] [Google Scholar]
  10. CHRISTIANSON L. C., DEWLETT H. J. Pulmonary disease in adults associated with unclassified mycobacteria. Am J Med. 1960 Dec;29:980–991. doi: 10.1016/0002-9343(60)90078-4. [DOI] [PubMed] [Google Scholar]
  11. CORPE R. F., RUNYON E. H., LESTER W. Status of disease due to unclassified mycobacteria. A statement of the Subcommittee on Unclassified Mycobacteria of the Committee on Therapy. Am Rev Respir Dis. 1963 Mar;87:459–461. doi: 10.1164/arrd.1963.87.3P1.459. [DOI] [PubMed] [Google Scholar]
  12. Corpe R. F. Surgical management of pulmonary disease due to Mycobacterium avium-intracellulare. Rev Infect Dis. 1981 Sep-Oct;3(5):1064–1067. doi: 10.1093/clinids/3.5.1064. [DOI] [PubMed] [Google Scholar]
  13. Crowle A. J., Sbarbaro J. A., Judson F. N., May M. H. The effect of ethambutol on tubercle bacilli within cultured human macrophages. Am Rev Respir Dis. 1985 Oct;132(4):742–745. doi: 10.1164/arrd.1985.132.4.742. [DOI] [PubMed] [Google Scholar]
  14. Djurovic V., Decroix G., Daumet P. L'éthambutol chez l'homme. Etude comparative des taux sériques, érythrocytaires et pulmonaires. Nouv Presse Med. 1973 Nov 24;2(42):2815–2816. [PubMed] [Google Scholar]
  15. ELSTON H. R., PARRILLO O. J., MEIBERGER M., KLEITSCH W. P. PULMONARY MYCOBACTERIOSIS: REPORT OF SEVEN CASES. Arch Intern Med. 1964 Mar;113:365–372. doi: 10.1001/archinte.1964.00280090051009. [DOI] [PubMed] [Google Scholar]
  16. Elston H. R., Duffy J. P. Mycobacterium xenopi and mycobacteriosis. A clinical bacteriologic report. Am Rev Respir Dis. 1973 Oct;108(4):944–949. doi: 10.1164/arrd.1973.108.4.944. [DOI] [PubMed] [Google Scholar]
  17. Engbaek H. C., Vergmann B., Bentzon M. W. A prospective study of lung disease caused by Mycobacterium avium/Mycobacterium intracellulare. Eur J Respir Dis. 1984 Aug;65(6):411–418. [PubMed] [Google Scholar]
  18. Fischer D. A., Lester W., Schaefer W. B. Infections with atypical mycobacteria. Five years' experience at the National Jewish Hospital. Am Rev Respir Dis. 1968 Jul;98(1):29–34. doi: 10.1164/arrd.1968.98.1.29. [DOI] [PubMed] [Google Scholar]
  19. France A. J., McLeod D. T., Calder M. A., Seaton A. Mycobacterium malmoense infections in Scotland: an increasing problem. Thorax. 1987 Aug;42(8):593–595. doi: 10.1136/thx.42.8.593. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Goldman K. P. Treatment of unclassified mycobacterial infection of the lungs. Thorax. 1968 Jan;23(1):94–99. doi: 10.1136/thx.23.1.94. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Greene J. B., Sidhu G. S., Lewin S., Levine J. F., Masur H., Simberkoff M. S., Nicholas P., Good R. C., Zolla-Pazner S. B., Pollock A. A. Mycobacterium avium-intracellulare: a cause of disseminated life-threatening infection in homosexuals and drug abusers. Ann Intern Med. 1982 Oct;97(4):539–546. doi: 10.7326/0003-4819-97-4-539. [DOI] [PubMed] [Google Scholar]
  22. HARRISON R. W., REIMANN A. F., LONG E. T., LESTER W., Jr, ADAMS W. E. Adverse surgical experience in the treatment of pulmonary disease caused by atypical acid-fast bacilli. J Thorac Cardiovasc Surg. 1959 Oct;38:481–500. [PubMed] [Google Scholar]
  23. Hawkins C. C., Gold J. W., Whimbey E., Kiehn T. E., Brannon P., Cammarata R., Brown A. E., Armstrong D. Mycobacterium avium complex infections in patients with the acquired immunodeficiency syndrome. Ann Intern Med. 1986 Aug;105(2):184–188. doi: 10.7326/0003-4819-105-2-184. [DOI] [PubMed] [Google Scholar]
  24. Heifets L. B. Synergistic effect of rifampin, streptomycin, ethionamide, and ethambutol on Mycobacterium intracellulare. Am Rev Respir Dis. 1982 Jan;125(1):43–48. doi: 10.1164/arrd.1982.125.1.43. [DOI] [PubMed] [Google Scholar]
  25. Hoffner S. E., Svenson S. B., Källenius G. Synergistic effects of antimycobacterial drug combinations on Mycobacterium avium complex determined radiometrically in liquid medium. Eur J Clin Microbiol. 1987 Oct;6(5):530–535. doi: 10.1007/BF02014241. [DOI] [PubMed] [Google Scholar]
  26. Hui J., Gordon N., Kajioka R. Permeability barrier to rifampin in mycobacteria. Antimicrob Agents Chemother. 1977 May;11(5):773–779. doi: 10.1128/aac.11.5.773. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Hunter A. M., Campbell I. A., Jenkins P. A., Smith A. P. Treatment of pulmonary infections caused by mycobacteria of the Mycobacterium avium-intracellulare complex. Thorax. 1981 May;36(5):326–329. doi: 10.1136/thx.36.5.326. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. JENKINS D. E., BAHAR D., CHOFNAS I., FOSTER R., BARKLEY H. T. The clinical problem of infection with atypical acidfast bacilli. Trans Am Clin Climatol Assoc. 1959;71:21–33. [PMC free article] [PubMed] [Google Scholar]
  29. Johanson W. G., Jr, Nicholson D. P. Pulmonary disease due to Mycobacterium Kansasii. An analysis of some factors affecting prognosis. Am Rev Respir Dis. 1969 Jan;99(1):73–85. doi: 10.1164/arrd.1969.99.1.73. [DOI] [PubMed] [Google Scholar]
  30. Johnson J. D., Hand W. L., Francis J. B., King-Thompson N., Corwin R. W. Antibiotic uptake by alveolar macrophages. J Lab Clin Med. 1980 Mar;95(3):429–439. [PubMed] [Google Scholar]
  31. Kilburn J. O., Greenberg J. Effect of ethambutol on the viable cell count in Mycobacterium smegmatis. Antimicrob Agents Chemother. 1977 Mar;11(3):534–540. doi: 10.1128/aac.11.3.534. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Kilburn J. O., Takayama K., Armstrong E. L., Greenberg J. Effects of ethambutol on phospholipid metabolism in Mycobacterium smegmatis. Antimicrob Agents Chemother. 1981 Feb;19(2):346–348. doi: 10.1128/aac.19.2.346. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Kilburn J. O., Takayama K. Effects of ethambutol on accumulation and secretion of trehalose mycolates and free mycolic acid in Mycobacterium smegmatis. Antimicrob Agents Chemother. 1981 Sep;20(3):401–404. doi: 10.1128/aac.20.3.401. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Koizumi J. H., Sommers H. M. Mycobacterium xenopi and pulmonary disease. Am J Clin Pathol. 1980 Jun;73(6):826–830. doi: 10.1093/ajcp/73.6.826. [DOI] [PubMed] [Google Scholar]
  35. Kuze F. Experimental chemotherapy in chronic Mycobacterium avium-intracellulare infection of mice. Am Rev Respir Dis. 1984 Mar;129(3):453–459. doi: 10.1164/arrd.1984.129.3.453. [DOI] [PubMed] [Google Scholar]
  36. LAW S. W. SURGICAL TREATMENT OF ATYPICAL MYCOBACTERIAL DISEASE; A SURVEY OF EXPERIENCE IN VETERANS ADMINISTRATION HOSPITALS. Dis Chest. 1965 Mar;47:296–303. doi: 10.1378/chest.47.3.296. [DOI] [PubMed] [Google Scholar]
  37. LEWIS A. G., Jr, DUNBAR F. P., LASCHE E. M., BOND J. O., LERNER E. N., WHARTON D. J., HARDY A. V., DAVIES R. Chronic pulmonary disease due to atypical mycobacterial infections. Am Rev Respir Dis. 1959 Aug;80:188–199. doi: 10.1164/arrd.1959.80.2.188. [DOI] [PubMed] [Google Scholar]
  38. Leff D. R., Leff A. R. Current treatment modes for tuberculosis. Public policy and implementation. Chest. 1985 Feb;87(2):139–140. doi: 10.1378/chest.87.2.139. [DOI] [PubMed] [Google Scholar]
  39. Lester T. W. Drug-resistant and atypical mycobacterial disease. Bacteriology and treatment. Arch Intern Med. 1979 Dec;139(12):1399–1401. [PubMed] [Google Scholar]
  40. Lester W. Unclassified mycobacterial diseases. Annu Rev Med. 1966;17:351–360. doi: 10.1146/annurev.me.17.020166.002031. [DOI] [PubMed] [Google Scholar]
  41. Liss R. H. Antimycobacterial activity of ethambutol in human pulmonary mononuclear phagocytes. Prax Klin Pneumol. 1983 Oct;37 (Suppl 1):485–486. [PubMed] [Google Scholar]
  42. Marinelli D. L., Albelda S. M., Williams T. M., Kern J. A., Iozzo R. V., Miller W. T. Nontuberculous mycobacterial infection in AIDS: clinical, pathologic, and radiographic features. Radiology. 1986 Jul;160(1):77–82. doi: 10.1148/radiology.160.1.3715048. [DOI] [PubMed] [Google Scholar]
  43. Marks J. A system for the examination of tubercle bacilli and other mycobacteria. Tubercle. 1976 Sep;57(3):207–225. doi: 10.1016/0041-3879(76)90030-1. [DOI] [PubMed] [Google Scholar]
  44. Moran J. F., Alexander L. G., Staub E. W., Young W. G., Jr, Sealy W. C. Long-term results of pulmonary resection for atypical mycobacterial disease. Ann Thorac Surg. 1983 Jun;35(6):597–604. doi: 10.1016/s0003-4975(10)61069-7. [DOI] [PubMed] [Google Scholar]
  45. Nash D. R., Steingrube V. A. Selecting drug combinations for treatment of drug-resistant mycobacterial diseases. J Clin Pharmacol. 1982 Jul;22(7):297–300. doi: 10.1002/j.1552-4604.1982.tb02678.x. [DOI] [PubMed] [Google Scholar]
  46. PFUETZE K. H., LEVAN V. O., REIMANN A. F., BERG G. S., LESTER W. PHOTOCHROMOGENIC MYCOBACTERIAL PULMONARY DISEASE. Am Rev Respir Dis. 1965 Sep;92:470–475. doi: 10.1164/arrd.1965.92.3.470. [DOI] [PubMed] [Google Scholar]
  47. PHILLIPS S., LARKIN J. C., Jr ATYPICAL PULMONARY TUBERCULOSIS CAUSED BY UNCLASSIFIED MYCOBACTERIA. Ann Intern Med. 1964 Mar;60:401–408. doi: 10.7326/0003-4819-60-3-401. [DOI] [PubMed] [Google Scholar]
  48. Rauscher C. R., Kerby G., Ruth W. E. A ten-year clinical experience with Mycobacterium kansasii. Chest. 1974 Jul;66(1):17–19. doi: 10.1378/chest.66.1.17. [DOI] [PubMed] [Google Scholar]
  49. Rosenzweig D. Y. Pulmonary mycobacterial infections due to Mycobacterium intracellulare-avium complex. Clinical features and course in 100 consecutive cases. Chest. 1979 Feb;75(2):115–119. doi: 10.1378/chest.75.2.115. [DOI] [PubMed] [Google Scholar]
  50. Rynearson T. K., Shronts J. S., Wolinsky E. Rifampin: in vitro effect on atypical mycobacteria. Am Rev Respir Dis. 1971 Aug;104(2):272–274. doi: 10.1164/arrd.1971.104.2.272. [DOI] [PubMed] [Google Scholar]
  51. Shah H. H., Holland R. H., Meador R. S., Webb W. R. The surgical variations of pulmonary infections caused by different species of Mycobacteria. Ann Thorac Surg. 1969 Feb;7(2):145–149. doi: 10.1016/s0003-4975(10)66160-7. [DOI] [PubMed] [Google Scholar]
  52. Sippel A., Hartmann G. Mode of action of rafamycin on the RNA polymerase reaction. Biochim Biophys Acta. 1968 Mar 18;157(1):218–219. doi: 10.1016/0005-2787(68)90286-4. [DOI] [PubMed] [Google Scholar]
  53. Smith M. J., Citron K. M. Clinical review of pulmonary disease caused by Mycobacterium xenopi. Thorax. 1983 May;38(5):373–377. doi: 10.1136/thx.38.5.373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Takayama K., Armstrong E. L., Kunugi K. A., Kilburn J. O. Inhibition by ethambutol of mycolic acid transfer into the cell wall of Mycobacterium smegmatis. Antimicrob Agents Chemother. 1979 Aug;16(2):240–242. doi: 10.1128/aac.16.2.240. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Tellis C. J., Beechler C. R., Ohashi D. K., Fuller S. A. Pulmonary disease caused by Mycobacterium xenopi:two case reports. Am Rev Respir Dis. 1977 Oct;116(4):779–783. doi: 10.1164/arrd.1977.116.4.779. [DOI] [PubMed] [Google Scholar]
  56. Thibier R., Vivien J. N., Lepeuple A. Sept cas de pleuro-pneumopathie a "Mycobacterium xenopei". Rev Tuberc Pneumol (Paris) 1970 Jul-Aug;34(5):623–625. [PubMed] [Google Scholar]
  57. Tsang A. Y., Bentz R. R., Schork M. A., Sodeman T. M. Combined vs. single-drug studies of susceptibilities of Mycobacterium kansasii to isoniazid, streptomycin, and ethambutol. Am J Clin Pathol. 1978 Nov;70(5):816–820. doi: 10.1093/ajcp/70.5.816. [DOI] [PubMed] [Google Scholar]
  58. Tsukamura M. The pattern of resistance development to rifampicin in Mycobacterium tuberculosis. Tubercle. 1972 Jun;53(2):111–117. doi: 10.1016/0041-3879(72)90027-x. [DOI] [PubMed] [Google Scholar]
  59. WOOD L. E., BUHLER V. B., POLLAK A. Human infection with the yellow acid-fast bacillus; a report of fifteen additional cases. Am Rev Tuberc. 1956 Jun;73(6):917–929. doi: 10.1164/artpd.1956.73.6.917. [DOI] [PubMed] [Google Scholar]
  60. Wallace J. M., Hannah J. B. Mycobacterium avium complex infection in patients with the acquired immunodeficiency syndrome. A clinicopathologic study. Chest. 1988 May;93(5):926–932. doi: 10.1378/chest.93.5.926. [DOI] [PubMed] [Google Scholar]
  61. Wehrli W., Knüsel F., Schmid K., Staehelin M. Interaction of rifamycin with bacterial RNA polymerase. Proc Natl Acad Sci U S A. 1968 Oct;61(2):667–673. doi: 10.1073/pnas.61.2.667. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Yeager H., Jr, Raleigh J. W. Pulmonary disease due to Mycobacterium intracellulare. Am Rev Respir Dis. 1973 Sep;108(3):547–552. doi: 10.1164/arrd.1973.108.3.547. [DOI] [PubMed] [Google Scholar]
  63. Zakowski P., Fligiel S., Berlin G. W., Johnson L., Jr Disseminated Mycobacterium avium-intracellulare infection in homosexual men dying of acquired immunodeficiency. JAMA. 1982 Dec 10;248(22):2980–2982. doi: 10.1001/jama.1982.03330220024029. [DOI] [PubMed] [Google Scholar]
  64. Zimmer B. L., DeYoung D. R., Roberts G. D. In vitro synergistic activity of ethambutol, isoniazid, kanamycin, rifampin, and streptomycin against Mycobacterium avium-intracellulare complex. Antimicrob Agents Chemother. 1982 Jul;22(1):148–150. doi: 10.1128/aac.22.1.148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Zvetina J. R., Neville W. E., Maben H. C., Langston H. T., Correll N. O., Jr Surgical treatment of pulmonary disease due to Mycobacterium kansasii. Ann Thorac Surg. 1971 Jun;11(6):551–556. doi: 10.1016/s0003-4975(10)65071-0. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES